These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3469194)

  • 21. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
    Lode H; Wiley R; Höffken G; Wagner J; Borner K
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with imipenem/cilastatin in the intensive care unit.
    Rouveix E; Bure AM; Regnier B; Wolff M; Pangon B; Laisne MJ; Vachon F
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():153-60. PubMed ID: 3469188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imipenem/cilastatin.
    Lancet; 1988 Aug; 2(8607):376-7. PubMed ID: 2899781
    [No Abstract]   [Full Text] [Related]  

  • 26. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C; Pappas F; Cook T
    Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
    Verbist L; Verpooten GA; Giuliano RA; Debroe ME; Buntinx AP; Entwistle LA; Jones KH
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
    Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imipenem-cilastatin sodium (Primaxin).
    Med Lett Drugs Ther; 1986 Mar; 28(709):29-31. PubMed ID: 3512968
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Chimura T; Morisaki N; Matsuo M
    Jpn J Antibiot; 1986 Jun; 39(6):1519-25. PubMed ID: 3463793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primaxin in the treatment of acute bacterial pneumonia in adults.
    Gebhart RJ; Duma RJ; Patterson PM; Bagett JW; Williams DS
    J Antimicrob Chemother; 1985 Feb; 15(2):233-8. PubMed ID: 3980311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of imipenem-cilastatin therapy on fecal flora.
    Welkon CJ; Long SS; Gilligan PH
    Antimicrob Agents Chemother; 1986 May; 29(5):741-3. PubMed ID: 3460522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Horii T; Noda K
    Jpn J Antibiot; 1986 Jun; 39(6):1601-6. PubMed ID: 3463800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with imipenem/cilastatin: analysis of a multicenter study.
    Shah PM
    Rev Infect Dis; 1985; 7 Suppl 3():S471-5. PubMed ID: 3901210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
    Gruber WC; Rench MA; Garcia-Prats JA; Edwards MS; Baker CJ
    Antimicrob Agents Chemother; 1985 Apr; 27(4):511-4. PubMed ID: 3859243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.
    Fan W; del Busto R; Love M; Markowitz N; Cendrowski C; Cardenas J; Quinn E; Saravolatz L
    Antimicrob Agents Chemother; 1986 Jan; 29(1):26-9. PubMed ID: 3460521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imipenem/cilastatin in the treatment of severe hospital infections.
    Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A
    Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipenem/cilastatin in the treatment of serious bacterial infections.
    Chiodini PL; Geddes AM; Smith EG; Conlon CP; Farrell ID
    Rev Infect Dis; 1985; 7 Suppl 3():S490-5. PubMed ID: 3901212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of imipenem-cilastatin in neonates.
    Freij BJ; McCracken GH; Olsen KD; Threlkeld N
    Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.